Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

RISANKIZUMAB-RZAA

FDA · BLA · 2026-06-26

AgencyFDA
Submission typeBLA
Action date2026-06-26
BrandSKYRIZI
SponsorABBVIE INC
RouteINJECTION

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T03:30:41.070Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:RISANKIZUMAB-RZAA:2026-06-26

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

RISANKIZUMAB-RZAA — approval | AEaH